Regulus Therapeutics Inc. (RGLS) Ownership

$1.69

south_east
-$0.12 (-6.39%)
Day's range
$1.62
Day's range
$1.81

Regulus Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FEDERATED HERMES, INC. 02/13/2025 12.85 M $20.31 M   0.00% 19.63%
NEA MANAGEMENT COMPANY, LLC 02/14/2025 6.47 M $10.22 M   0.00% 9.88%
VIVO CAPITAL, LLC 02/13/2025 5.00 M $7.90 M   0.00% 7.64%
OCTAGON CAPITAL ADVISORS LP 02/14/2025 4.85 M $7.66 M   13.72% 7.41%
BLACKROCK, INC. 02/07/2025 4.24 M $6.69 M   3.81% 6.47%
VANGUARD GROUP INC 02/11/2025 3.97 M $6.27 M   -2.98% 6.06%
DEEP TRACK CAPITAL, LP 02/14/2025 3.26 M $5.15 M   0.00% 4.98%
MILLENNIUM MANAGEMENT LLC 02/14/2025 2.19 M $3.46 M   69.75% 3.35%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 2.00 M $3.16 M   0.00% 3.05%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.28 M $2.02 M   -0.10% 1.95%
STATE STREET CORP 02/14/2025 1.06 M $1.67 M   5.54% 1.61%
ALYESKA INVESTMENT GROUP, L.P. 02/14/2025 1.04 M $1.64 M   0.00% 1.58%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 895,128 $1.41 M   0.15% 1.37%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 875,200 $1.38 M   -2.23% 1.34%
NORTHERN TRUST CORP 02/14/2025 457,233 $722,428   -8.06% 0.70%
VICTORY CAPITAL MANAGEMENT INC 02/06/2025 389,886 $616,020   -2.25% 0.60%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 336,843 $532,212   -56.07% 0.51%
GOLDMAN SACHS GROUP INC 02/11/2025 212,379 $335,559   18.64% 0.32%
JPMORGAN CHASE & CO 02/12/2025 190,457 $300,922   141.17% 0.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 178,879 $282,629   0.00% 0.27%
CITADEL ADVISORS LLC 02/14/2025 155,558 $245,782   486,018.75% 0.24%
BANK OF NEW YORK MELLON CORP 02/04/2025 149,355 $235,981   0.00% 0.23%
MORGAN STANLEY 02/14/2025 139,791 $220,870   -16.83% 0.21%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 117,100 $185,018   20.47% 0.18%
TYCHE WEALTH PARTNERS LLC 01/27/2025 106,089 $167,621   0.00% 0.16%
BARCLAYS PLC 02/13/2025 96,247 $152,000   13.93% 0.15%
UBS GROUP AG 02/14/2025 90,147 $142,432   201.74% 0.14%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 85,602 $135,251   0.00% 0.13%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 02/14/2025 70,000 $110,600   100.00% 0.11%
PEAK6 LLC 02/13/2025 60,000 $94,800   100.00% 0.09%
RHUMBLINE ADVISERS 01/30/2025 59,531 $94,052   -20.09% 0.09%
BANK OF AMERICA CORP /DE/ 02/14/2025 53,841 $85,068   -1.08% 0.08%
CITIGROUP INC 02/12/2025 50,138 $79,218   -6.69% 0.08%
LPL FINANCIAL LLC 02/11/2025 49,980 $78,968   -13.80% 0.08%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 49,400 $78,000   0.00% 0.08%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 36,701 $57,988   4.40% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 36,188 $57,177   100.00% 0.06%
WELLS FARGO & COMPANY/MN 02/13/2025 35,159 $55,551   32.25% 0.05%
COREBRIDGE FINANCIAL, INC. 02/11/2025 31,397 $49,607   -7.02% 0.05%
INVESCO LTD. 02/13/2025 30,248 $47,792   7.06% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 29,597 $47,000   -98.62% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 02/11/2025 28,480 $44,998   100.00% 0.04%
ALLIANCEBERNSTEIN L.P. 02/12/2025 26,880 $42,470   0.00% 0.04%
VOYA INVESTMENT MANAGEMENT LLC 02/14/2025 23,074 $36,457   0.00% 0.04%
TWO SIGMA INVESTMENTS, LP 02/14/2025 22,264 $35,177   16.07% 0.03%
PROSHARE ADVISORS LLC 02/14/2025 17,785 $28,099   49.05% 0.03%
CREATIVE PLANNING 02/14/2025 14,116 $22,303   -14.27% 0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 13,700 $21,646   -62.36% 0.02%
02/11/2025 12,696 $20,060   100.00% 0.02%
COMMONWEALTH EQUITY SERVICES, LLC 02/10/2025 11,700 $18,000   1.74% 0.02%

Regulus Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 78 institutional investors and hedge funds held shares of Regulus Therapeutics Inc.. The most heavily invested institutionals were:

FEDERATED HERMES, INC.: 12.85 M

NEA Management Company, LLC: 6.47 M

Vivo Capital, LLC: 5 M

Octagon Capital Advisors LP: 4.85 M

BlackRock, Inc.: 4.24 M

VANGUARD GROUP INC: 3.97 M

81.73% of Regulus Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 57.90 M shares in the last 24 months. This purchase volume represents approximately $97.56 M in transactions.